DataVXJournal of Materials SciencePaper
journal article·2024-12

A platform of gold nanoparticles coated with silica as controlled drug delivery for application in cancer treatment

Isabela Barreto da Costa Januário Meireles, André Felipe Oliveira, Michele Angela Rodrigues, Edésia Martins Barros de Sousa

Journal of Materials Science· Volume 59· Issue 48
Publisher page
Bibliographic record

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

Nanomaterials

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (70)

Show source-provided references
1. Qu X, Zhou D, Lu J et al (2023) Cancer nanomedicine in preoperative therapeutics: nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy, and phototherapy. Bioact Mater 24:136–152. https://doi.org/10.1016/j.bioactmat.2022.12.01010.1016/j.bioactmat.2022.12.010 ↗
2. Chabner BA, Roberts TG Jr (2005) Chemotherapy and the war on cancer. Nat Rev Cancer 5:65–72. https://doi.org/10.1038/nrc152910.1038/nrc1529 ↗
3. Shewach DS, Kuchta RD (2009) Introduction to cancer chemotherapeutics. Chem Rev 109:2859–2861. https://doi.org/10.1021/cr900208x10.1021/cr900208x ↗
4. Smith S, Prewett S (2020) Principles of chemotherapy and radiotherapy. Obstet Gynaecol Reprod Med 30:72–78. https://doi.org/10.1016/j.ogrm.2019.12.00410.1016/j.ogrm.2019.12.004 ↗
5. Katturajan R, RasoolPrince MSE (2021) Molecular toxicity of methotrexate in rheumatoid arthritis treatment: a novel perspective and therapeutic implications. Toxicology 461:152909. https://doi.org/10.1016/j.tox.2021.15290910.1016/j.tox.2021.152909 ↗
6. Wang W, Zhou H, Liu L (2018) Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem 158:502–516. https://doi.org/10.1016/j.ejmech.2018.09.02710.1016/j.ejmech.2018.09.027 ↗
7. Alexa IF, Pastravanu CG, Ignat M, Popovici E (2013) A comparative study on long-term MTX controlled release from intercalated nanocomposites for nanomedicine applications. Colloids Surf B Biointerfaces 106:135–139. https://doi.org/10.1016/j.colsurfb.2013.01.02210.1016/j.colsurfb.2013.01.022 ↗
8. Li X, Wang H, Zou X et al (2022) Methotrexate-loaded folic acid of solid-phase synthesis conjugated gold nanoparticles targeted treatment for rheumatoid arthritis. Eur J Pharm Sci 170:106101. https://doi.org/10.1016/j.ejps.2021.10610110.1016/j.ejps.2021.106101 ↗
9. Khizar S, Alrushaid N, Khan FA et al (2023) Nanocarriers based novel and effective drug delivery system. Int J Pharm 632:122570. https://doi.org/10.1016/j.ijpharm.2022.12257010.1016/j.ijpharm.2022.122570 ↗
10. Ioele G, Chieffallo M, Occhiuzzi MA et al (2022) Anticancer drugs: recent strategies to improve stability profile. Pharmacokinetic Pharm Prop Mol 27:5436. https://doi.org/10.3390/molecules2717543610.3390/molecules27175436 ↗
11. Chandrakala V, Aruna V, Angajala G (2022) Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems. Emergent Mater 5:1593–1615. https://doi.org/10.1007/s42247-021-00335-x10.1007/s42247-021-00335-x ↗
12. Attia MF, Anton N, Wallyn J et al (2019) An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol 71:1185–1198. https://doi.org/10.1111/jphp.1309810.1111/jphp.13098 ↗
13. Ang MJY, Chan SY, Goh YY et al (2021) Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics. Adv Drug Deliv Rev 178:113907. https://doi.org/10.1016/j.addr.2021.11390710.1016/j.addr.2021.113907 ↗
14. Sultana A, Zare M, Thomas V et al (2022) Nano-based drug delivery systems: conventional drug delivery routes, recent developments and future prospects. Med Drug Discov 15:100134. https://doi.org/10.1016/j.medidd.2022.10013410.1016/j.medidd.2022.100134 ↗
15. Freitas LBO, Bravo IJG, de Macedo WA (2016) Mesoporous silica materials functionalized with folic acid: preparation, characterization and release profile study with methotrexate. J Solgel Sci Technol 77:186–204. https://doi.org/10.1007/s10971-015-3844-810.1007/s10971-015-3844-8 ↗
16. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–4021. https://doi.org/10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
17. Abouaitah K, Lojkowski W (2021) Delivery of natural agents by means of mesoporous silica nanospheres as a promising anticancer strategy. Pharmaceutics 13:143. https://doi.org/10.3390/pharmaceutics1302014310.3390/pharmaceutics13020143 ↗
18. Dang Y, Guan J (2020) Nanoparticle-based drug delivery systems for cancer therapy. Smart Mater Med 1:10–19. https://doi.org/10.1016/j.smaim.2020.04.00110.1016/j.smaim.2020.04.001 ↗
19. Cheng Z, Li M, Dey R, Chen Y (2021) Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol 14:85. https://doi.org/10.1186/s13045-021-01096-010.1186/s13045-021-01096-0 ↗
20. Singh M, Harris-Birtill DCC, Markar SR et al (2015) Application of gold nanoparticles for gastrointestinal cancer theranostics: a systematic review. Nanomedicine 11:2083–2098. https://doi.org/10.1016/j.nano.2015.05.01010.1016/j.nano.2015.05.010 ↗
21. Ali ES, Sharker SM, Islam MT et al (2021) Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives. Semin Cancer Biol 69:52–68. https://doi.org/10.1016/j.semcancer.2020.01.01110.1016/j.semcancer.2020.01.011 ↗
22. Alasvand N, Urbanska AM, Rahmati M et al (2017) Therapeutic nanoparticles for targeted delivery of anticancer drugs. In: Grumezescu AM (ed) Multifunctional Systems for Combined Delivery. Elsevier Inc, Amsterdam, pp 245–259
23. Liu CG, Han YH, Kankala RK et al (2020) Subcellular performance of nanoparticles in cancer therapy. Int J Nanomed 15:675–704. https://doi.org/10.2147/IJN.S22618610.2147/IJN.S226186 ↗
24. Ghazimoradi M, Tarlani A, Alemi A et al (2023) pH-responsive, magnetic-luminescent core/shell carriers for co-delivery of anticancer drugs (MTX and DOX) for breast cancer treatment. J Alloys Compd 936:168257. https://doi.org/10.1016/j.jallcom.2022.16825710.1016/j.jallcom.2022.168257 ↗
25. Hamimed S, Jabberi M, Chatti A (2022) Nanotechnology in drug and gene delivery. Naunyn Schmiedebergs Arch Pharmacol 395:769–787. https://doi.org/10.1007/s00210-022-02245-z10.1007/s00210-022-02245-z ↗
26. Patra JK, Das G, Fraceto LF et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotech 16:71. https://doi.org/10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
27. Adepu S, Ramakrishna S (2021) Controlled drug delivery systems: current status and future directions. Molecules 26:5905. https://doi.org/10.3390/molecules2619590510.3390/molecules26195905 ↗
28. Sun L, Liu H, Ye Y et al (2023) Smart nanoparticles for cancer therapy. Signal Transduct Target Ther 8:418. https://doi.org/10.1038/s41392-023-01642-x10.1038/s41392-023-01642-x ↗
29. Gonzalez-Carter DA, Ong ZY, McGilvery CM et al (2019) L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles. Nanomedicine 15:1–11. https://doi.org/10.1016/j.nano.2018.08.01110.1016/j.nano.2018.08.011 ↗
30. Taghizadeh S, Alimardani V, Roudbali PL et al (2019) Gold nanoparticles application in liver cancer. Photodiagnosis Photodyn Ther 25:389–400. https://doi.org/10.1016/j.pdpdt.2019.01.02710.1016/j.pdpdt.2019.01.027 ↗
31. Austin LA, MacKey MA, Dreaden EC, El-Sayed MA (2014) The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery. Arch Toxicol 88:1391–1417. https://doi.org/10.1007/s00204-014-1245-310.1007/s00204-014-1245-3 ↗
32. Mohammad F, Yusof NA (2014) Doxorubicin-loaded magnetic gold nanoshells for a combination therapy of hyperthermia and drug delivery. J Colloid Interface Sci 434:89–97. https://doi.org/10.1016/j.jcis.2014.07.02510.1016/j.jcis.2014.07.025 ↗
33. Zhang M, Zhang X, Zhao K et al (2022) Assembly of gold nanorods with L-cysteine reduced graphene oxide for highly efficient NIR-triggered photothermal therapy. Spectrochim Acta A Mol Biomol Spectrosc 266:120458. https://doi.org/10.1016/j.saa.2021.12045810.1016/j.saa.2021.120458 ↗
34. Ruttala HB, Ramasamy T, Poudel BK et al (2020) Multi-responsive albumin-lonidamine conjugated hybridized gold nanoparticle as a combined photothermal-chemotherapy for synergistic tumor ablation. Acta Biomater 101:531–543. https://doi.org/10.1016/j.actbio.2019.11.00310.1016/j.actbio.2019.11.003 ↗
35. Beik J, Khateri M, Khosravi Z et al (2019) Gold nanoparticles in combinatorial cancer therapy strategies. Coord Chem Rev 387:299–324. https://doi.org/10.1016/j.ccr.2019.02.02510.1016/j.ccr.2019.02.025 ↗
36. Chuang CC, Cheng CC, Chen PY et al (2019) Gold nanorod-encapsulated biodegradable polymeric matrix for combined photothermal and chemo-cancer therapy. Int J Nanomed 14:181–193. https://doi.org/10.2147/IJN.S17785110.2147/IJN.S177851 ↗
37. Fan W, Yung B, Huang P, Chen X (2017) Nanotechnology for multimodal synergistic cancer therapy. Chem Rev 117:13566–13638. https://doi.org/10.1021/acs.chemrev.7b0025810.1021/acs.chemrev.7b00258 ↗
38. Zhang Y, Yan H, Tang J et al (2022) Dual-mode antibacterial core-shell gold nanorod@mesoporous-silica/curcumin nanocomplexes for efficient photothermal and photodynamic therapy. J Photochem Photobiol A Chem 425:113722. https://doi.org/10.1016/j.jphotochem.2021.11372210.1016/j.jphotochem.2021.113722 ↗
39. Tiwari H, Rai N, Singh S et al (2023) Recent advances in nanomaterials-based targeted drug delivery for preclinical cancer diagnosis and therapeutics. Bioengineering 10:760. https://doi.org/10.3390/bioengineering1007076010.3390/bioengineering10070760 ↗
40. Liu J, Cabral H, Mi P (2024) Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release. Adv Drug Deliv Rev 207:115239. https://doi.org/10.1016/j.addr.2024.11523910.1016/j.addr.2024.115239 ↗
41. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:1278–1288. https://doi.org/10.1016/j.addr.2008.03.01210.1016/j.addr.2008.03.012 ↗
42. Chenthamara D, Subramaniam S, Ramakrishnan SG et al (2019) Therapeutic efficacy of nanoparticles and routes of administration. Biomater Res 23:20. https://doi.org/10.1186/s40824-019-0166-x10.1186/s40824-019-0166-x ↗
43. Miao L, Wei Y, Lu X et al (2024) Interaction of 2D nanomaterial with cellular barrier: membrane attachment and intracellular trafficking. Adv Drug Deliv Rev 204:115131. https://doi.org/10.1016/j.addr.2023.11513110.1016/j.addr.2023.115131 ↗
44. Elshoky HA, El-Sayed NM, Hassouna YH et al (2023) Improved in vitro biocompatibility and cytoplasmic localization of gold nanoparticles and graphene oxide nanosheets assessed using confocal microscopy. J Drug Deliv Sci Technol 86:104678. https://doi.org/10.1016/j.jddst.2023.10467810.1016/j.jddst.2023.104678 ↗
45. Meireles IB, Cipreste MF, Gastelois PL et al (2021) Synthesis and characterization of gold nanorods coated by mesoporous silica MCM-41 as a platform for bioapplication in photohyperthermia. Nanotechnology 32:505720. https://doi.org/10.1088/1361-6528/ac28db10.1088/1361-6528/ac28db ↗
46. Elbialy N, Mohamed N, Monem AS (2014) Synthesis, characterization and application of gold nanoshells using mesoporous silica core. Microporous Mesoporous Mater 190:197–207. https://doi.org/10.1016/j.micromeso.2014.02.00310.1016/j.micromeso.2014.02.003 ↗
47. Monem AS, Elbialy N, Mohamed N (2014) Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy. Int J Pharm 470:1–7. https://doi.org/10.1016/j.ijpharm.2014.04.06710.1016/j.ijpharm.2014.04.067 ↗
48. Xu C, Niu Y, Popat A et al (2014) Rod-like mesoporous silica nanoparticles with rough surfaces for enhanced cellular delivery. J Mater Chem B 2:253–256. https://doi.org/10.1039/c3tb21431a10.1039/c3tb21431a ↗
49. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675. https://doi.org/10.1038/nmeth.208910.1038/nmeth.2089 ↗
50. De Miranda MC, Rodrigues MA, Campos ACA et al (2019) Epidermal growth factor (EGF) triggers nuclear calcium signaling through the intranuclear phospholipase Cδ-4 (PLCδ4). J Bio Chem 294:16650–16662. https://doi.org/10.1074/jbc.RA118.00696110.1074/jbc.RA118.006961 ↗
51. Kong Y, Zhu H, Yang G et al (2004) Investigation of the structure of MCM-41 samples with a high copper content. Adv Funct Mater 14:816–820. https://doi.org/10.1002/adfm.20030511110.1002/adfm.200305111 ↗
52. Zhou C, Gao Q, Luo W et al (2015) Preparation, characterization and adsorption evaluation of spherical mesoporous Al-MCM-41 from coal fly ash. J Taiwan Inst Chem Eng 52:147–157. https://doi.org/10.1016/j.jtice.2015.02.01410.1016/j.jtice.2015.02.014 ↗
53. Rasouli S, Davaran S, Rasouli F et al (2013) Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery. Drug Deliv 21:155–163. https://doi.org/10.3109/10717544.2013.83871410.3109/10717544.2013.838714 ↗
54. Álvarez-González B, Rozalen M, Fernández-Perales M et al (2020) Methotrexate gold nanocarriers: loading and release study: its activity in colon and lung cancer cells. Molecules 25:6049. https://doi.org/10.3390/molecules2524604910.3390/molecules25246049 ↗
55. Rui Q, Yin Z-Z, Cai W et al (2022) Hyaluronic acid encapsulated aminated mesoporous silica nanoparticles for pH-responsive delivery of methotrexate and release kinetics. Bull Korean Chem Soc 43:650–657. https://doi.org/10.1002/bkcs.1249910.1002/bkcs.12499 ↗
56. Akpotu SO, Moodley B (2016) Synthesis and characterization of citric acid grafted MCM-41 and its adsorption of cationic dyes. J Environ Chem Eng 4:4503–4513. https://doi.org/10.1016/j.jece.2016.10.01610.1016/j.jece.2016.10.016 ↗
57. Pang J, Zhao L, Zhang L et al (2013) Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery. J Colloid Interface Sci 395:31–39. https://doi.org/10.1016/j.jcis.2012.12.01610.1016/j.jcis.2012.12.016 ↗
58. Shi Z, Yang C, Li R, Ruan L (2020) Microwave thermal-triggered drug delivery using thermosensitive peptide-coated core–shell mesoporous silica nanoparticles. J Mater Sci 55:6118–6129. https://doi.org/10.1007/s10853-020-04428-610.1007/s10853-020-04428-6 ↗
59. Mori N, Kawasaki H, Nishida E et al (2023) Rose bengal-decorated rice husk-derived silica nanoparticles enhanced singlet oxygen generation for antimicrobial photodynamic inactivation. J Mater Sci 58:2801–2813. https://doi.org/10.1007/s10853-023-08194-z10.1007/s10853-023-08194-z ↗
60. Andrade GF, Soares DCF, Dos Santos RG, Sousa EMB (2013) Mesoporous silica SBA-16 nanoparticles: synthesis, physicochemical characterization, release profile, and in vitro cytocompatibility studies. Microporous Mesoporous Mater 168:102–110. https://doi.org/10.1016/j.micromeso.2012.09.03410.1016/j.micromeso.2012.09.034 ↗
61. Tian Y, Liu Y, Wang L et al (2021) Gadolinium-doped hollow silica nanospheres loaded with curcumin for magnetic resonance imaging-guided synergistic cancer sonodynamic-chemotherapy. Mater Sci Eng, C 126:112157. https://doi.org/10.1016/j.msec.2021.11215710.1016/j.msec.2021.112157 ↗
62. Zhao SN, Tang RH, Deng SJ et al (2023) Dual gatekeepers-modified dendritic mesoporous silica nanoparticles for controlled drug release. J Mater Sci 58:17610–17622. https://doi.org/10.1007/s10853-023-09128-510.1007/s10853-023-09128-5 ↗
63. Chen H, Kuang Y, Liu R et al (2018) Dual-pH-sensitive mesoporous silica nanoparticle-based drug delivery system for tumor-triggered intracellular drug release. J Mater Sci 53:10653–10665. https://doi.org/10.1007/s10853-018-2363-810.1007/s10853-018-2363-8 ↗
64. Devi S, Kaur R, Singh B et al (2018) Fluorescent sensing assay for trinitrotoluene using fluorescein isothiocyanate conjugated mesoporous MCM-41 particles. J Nanosci Nanotechnol 18:6838–6849. https://doi.org/10.1166/jnn.2018.1545610.1166/jnn.2018.15456 ↗
65. AbouAitah K, Swiderska-Sroda A, Farghali AA, Wojnarowicz J, Stefanek A, Gierlotka S, Opalinska A, Allayeh AK, Ciach T, Lojkowski W (2018) Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. Oncotarget 9(41):26466–26490. https://doi.org/10.18632/oncotarget.2547010.18632/oncotarget.25470 ↗
66. Mahata MK, Lee KT (2019) Development of near-infrared sensitized core-shell-shell upconverting nanoparticles as pH-responsive probes. Nanoscale Adv 1:2372–2381. https://doi.org/10.1039/c9na00088g10.1039/c9na00088g ↗
67. Chen H, Shao L, Li Q, Wang J (2013) Gold nanorods and their plasmonic properties. Chem Soc Rev 42:2679–2724. https://doi.org/10.1039/c2cs35367a10.1039/c2cs35367a ↗
68. Sharma V, Park K, Srinivasarao M (2009) Colloidal dispersion of gold nanorods: historical background, optical properties, seed-mediated synthesis, shape separation and self-assembly. Mater Sci Eng R 65:1–38. https://doi.org/10.1016/j.mser.2009.02.00210.1016/j.mser.2009.02.002 ↗
69. Higuchi T (1961) Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 50:874–875. https://doi.org/10.1002/jps.260050101810.1002/jps.2600501018 ↗
70. Higuchi T (1963) Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–1149. https://doi.org/10.1002/jps.260052121010.1002/jps.2600521210 ↗